Jazz Pharmaceuticals
JAZZ
#1438
Rank
NZ$27.30 B
Marketcap
NZ$420.57
Share price
-1.27%
Change (1 day)
92.07%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): -NZ$0.32 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$4.43 Billion. In 2025 the company made an earning of -NZ$1.1 Billion a decrease over its 2024 earnings that were of NZ$0.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.32 Billion-71.56%
2025 -NZ$1.1 Billion-233.48%
2024 NZ$0.82 B57.87%
2023 NZ$0.52 B-179.92%
2022 -NZ$0.66 Billion230.37%
2021 -NZ$0.2 Billion-141.02%
2020 NZ$0.48 B-39.45%
2019 NZ$0.79 B-14.2%
2018 NZ$0.92 B20.03%
2017 NZ$0.77 B-17.15%
2016 NZ$0.93 B22.14%
2015 NZ$0.76 B187.64%
2014 NZ$0.26 B-50.79%
2013 NZ$0.53 B73.63%
2012 NZ$0.30 B41.69%
2011 NZ$0.21 B116.61%
2010 NZ$0.10 B262.77%
2009 NZ$27.82 M-111.33%
2008 -NZ$0.25 Billion1.31%
2007 -NZ$0.25 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$99.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.57 B-7,312.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
NZ$3.66 B-1,058.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-NZ$4.18 Billion 992.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$3.96 B-1,137.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel